Skip to content

Management of Combined Fracture Neck of Femur and Femoral Deformity in Osteogenesis Imperfecta Patient

Management of Combined Fracture Neck of Femur and Femoral Deformity in Osteogenesis Imperfecta Patient

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05878548
Acronym
OI
Enrollment
1
Registered
2023-05-26
Start date
2023-08-01
Completion date
2024-04-01
Last updated
2024-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteogenesis Imperfecta

Keywords

Osteogenesis imperfecta, fracture neck of femur, telescoping nail

Brief summary

O.I with NOF fixed by Wagner technique and telescoping nail

Detailed description

osteogenesis imperfecta (Sillence Type IV) sustained neck of femur fracture after fall on ground. He had proximal femoral anterolateral bowing on top of inserted rod 4 years ago. He was treated with corrective osteotomy and intramedullary telescoping nail for deformed femur and Wagner technique to fix NOF fracture. One year after operation the patient gained satisfactory functional outcome with union of NOF fracture and correction of femoral deformity. This rare case illustrates the anticipated difficulties in managing neck of femur fracture in osteogenesis imperfect patients. The method of fixation with Wagner technique can achieve stable fixation for solid healing in fragility fractures like this and the least interference with telescoping nail insertion.

Interventions

PROCEDUREcorrective osteotomy and intramedullary telescoping nail for deformed femur and Wagner technique to fix NOF fracture

corrective osteotomy and intramedullary telescoping nail for deformed femur and Wagner technique to fix NOF fracture

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

fixation with Wagner technique

Eligibility

Sex/Gender
ALL
Age
2 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

* OI

Exclusion criteria

* Not receiving Bisphosphonate

Design outcomes

Primary

MeasureTime frameDescription
modified McKay's criteria1 yearhip function score the higher the score the better outcome graded into excellent, Good , Fair and Poor

Countries

Egypt

Contacts

Primary ContactHesaham M Elbaseet, MD
drhesham20@aun.edu.eg+2001007780689

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026